KCM
WST icon

Kennedy Capital Management’s West Pharmaceutical WST Stock Holding History

Kennedy Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,210
Closed -$1.14M – 618
2025
Q2 		$1.14M Sell
5,210
-3,070
-37% -$656K 0.03% 495
2025
Q1 		$1.85M Buy
+8,280
New +$2.28M 0.04% 441
2024
Q4 		– Sell
-6,569
Closed -$1.97M – 744
2024
Q3 		$1.97M Buy
6,569
+278
+4% +$85.1K 0.04% 514
2024
Q2 		$2.07M Buy
6,291
+2,472
+65% +$874K 0.04% 510
2024
Q1 		$1.51M Buy
+3,819
New +$1.41M 0.03% 570
2022
Q2 		– Sell
-578
Closed -$237K – 635
2022
Q1 		$237K Buy
578
+1
+0.2% +$391 0.01% 584
2021
Q4 		$271K Hold
577
– – 0.01% 594
2021
Q3 		$245K Sell
577
-161
-22% -$67.9K 0.01% 616
2021
Q2 		$265K Hold
738
– – 0.01% 612
2021
Q1 		$208K Sell
738
-209
-22% -$59.8K ﹤0.01% 644
2020
Q4 		$268K Sell
947
-570
-38% -$160K 0.01% 642
2020
Q3 		$417K Sell
1,517
-879
-37% -$233K 0.01% 600
2020
Q2 		$544K Sell
2,396
-44,148
-95% -$8.67M 0.02% 602
2020
Q1 		$7.09M Sell
46,544
-19,054
-29% -$2.93M 0.26% 105
2019
Q4 		$9.86M Sell
65,598
-4,208
-6% -$613K 0.24% 117
2019
Q3 		$9.9M Sell
69,806
-3,755
-5% -$517K 0.25% 118
2019
Q2 		$9.21M Sell
73,561
-1,280
-2% -$151K 0.22% 149
2019
Q1 		$8.25M Buy
74,841
+2,955
+4% +$307K 0.19% 185
2018
Q4 		$7.05M Sell
71,886
-6,122
-8% -$664K 0.18% 211
2018
Q3 		$9.63M Buy
78,008
+657
+0.8% +$73.7K 0.18% 189
2018
Q2 		$7.68M Sell
77,351
-427
-0.5% -$39.3K 0.14% 250
2018
Q1 		$6.87M Sell
77,778
-840
-1% -$78.6K 0.13% 273
2017
Q4 		$7.76M Sell
78,618
-3,885
-5% -$381K 0.14% 243
2017
Q3 		$7.94M Sell
82,503
-1,263
-2% -$114K 0.14% 235
2017
Q2 		$7.92M Sell
83,766
-216,099
-72% -$19.9M 0.15% 218
2017
Q1 		$24.5M Buy
299,865
+19,477
+7% +$1.63M 0.43% 35
2016
Q4 		$23.8M Buy
280,388
+43,667
+18% +$3.43M 0.41% 38
2016
Q3 		$17.6M Sell
236,721
-30,448
-11% -$2.42M 0.34% 69
2016
Q2 		$20.3M Sell
267,169
-19,701
-7% -$1.43M 0.41% 40
2016
Q1 		$19.9M Sell
286,870
-49,286
-15% -$2.97M 0.4% 37
2015
Q4 		$20.2M Sell
336,156
-11,762
-3% -$708K 0.41% 33
2015
Q3 		$18.8M Sell
347,918
-2,342
-0.7% -$136K 0.39% 44
2015
Q2 		$20.3M Buy
350,260
+43,402
+14% +$2.42M 0.37% 54
2015
Q1 		$18.5M Sell
306,858
-26,374
-8% -$1.41M 0.32% 69
2014
Q4 		$17.7M Sell
333,232
-171,586
-34% -$8.58M 0.33% 61
2014
Q3 		$22.6M Sell
504,818
-98,596
-16% -$4.19M 0.44% 26
2014
Q2 		$25.5M Sell
603,414
-31,275
-5% -$1.34M 0.47% 20
2014
Q1 		$28M Sell
634,689
-10,855
-2% -$511K 0.53% 11
2013
Q4 		$31.7M Sell
645,544
-33,429
-5% -$1.56M 0.59% 9
2013
Q3 		$27.9M Sell
678,973
-38,259
-5% -$1.46M 0.54% 17
2013
Q2 		$25.2M Buy
+717,232
New +$23.6M 0.51% 13

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Kennedy Capital Management's WST Position: Q3 2025 in Review

Kennedy Capital Management sold out of West Pharmaceutical (WST) in Q3 2025, closing a stake of 5,210 shares — an estimated $1.14M sold.

Kennedy Capital Management first reported a position in WST in Q2 2013 and held it in 41 quarters. The position peaked at $31.7M in Q4 2013. 756 funds tracked by Wall St. Rank hold WST as of Q3 2025.

  • Kennedy Capital Management reported no remaining West Pharmaceutical position as of Q3 2025 after selling out during the quarter.
  • Kennedy Capital Management sold 5,210 West Pharmaceutical shares in Q3 2025, an estimated $1.14M.
  • Kennedy Capital Management first reported a position in West Pharmaceutical in Q2 2013 and held it in 41 quarters.
  • Kennedy Capital Management's West Pharmaceutical position peaked at $31.7M in Q4 2013.
  • 756 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2025.

Based on Kennedy Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.